Jan Dubowski

Dr. Jan Dubowski

Université de Sherbrooke, Sherbrooke, QC, Canada
+1
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
ENElnaz Nazemi
Elnaz Nazemi
SASrivatsa Aithal
Srivatsa Aithal
WHWalid M. Hassen
Walid M. Hassen
EFEric Frost
Eric Frost
Jan DubowskiJan Dubowski
Jan Dubowski


12 April 2013 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
DLDominic Lepage
Dominic Lepage
AJAlvaro Jiménez
Alvaro Jiménez
JBJacques Beauvais
Jacques Beauvais
Jan DubowskiJan Dubowski
Jan Dubowski
Modern miniaturization and the digitalization of characterization instruments greatly facilitate the diffusion of technological advances in new fields and generate innovative applications. The concept of a portable, inexpensive and semi-automated biosensing platform, or lab-on-a-chip, is a vision shared by many researchers and venture industries. Under this scope, we present a semiconductor monolithic integration approach to conduct surface plasmon resonance studies. This technology is already commonly used for biochemical characterization in pharmaceutical industries, but we have reduced the technological platform to a few nanometers in scale on a semiconductor chip. We evaluate the signal quality of this nanophotonic device using hyperspectral-imaging technology, and we compare its performance with that of a standard prism-based commercial system. Two standard biochemical agents are employed for this characterization study: bovine serum albumin and inactivated influenza A virus. Time resolutions of data acquisition varying between 360 and 2.2 s are presented, yielding 2.7×10−5–1.5×10−6 RIU resolutions, respectively.

26 March 2019 in ACS Omega
Verified
Journal Article
Open access
HSHemant Sharma
Hemant Sharma
JSJagpreet S. Sidhu
Jagpreet S. Sidhu
WHWalid M. Hassen
Walid M. Hassen
NSNarinder Singh
Narinder Singh
Jan DubowskiJan Dubowski
Jan Dubowski
The development of organic molecules to target nucleic acid is an active area of research at the interface of chemistry and biochemistry, which involves DNA binding, nuclear imaging, and antitumor studies. These molecules bind with DNA through covalent interactions, electrostatic interactions, or intercalation. However, they are less permeable to membrane, and they have a significant cytotoxicity, which limits their application under in vivo conditions. In the present work, various mono- and disubstituted 1,8-naphthalimides-based derivatives (S-12, S-13, S-15, and S-21) have been synthesized and characterized through various spectroscopic techniques. Among these, 3-amino-4-bromo-1,8-naphthalimide (S-15) was found to have an attractive water solubility and act as a nuclear imaging agent. The spectroscopic absorption and emission data showed that S-15 has a strong affinity for salmon sperm DNA with a binding constant of 6.61 × 104 M–1, and the ratiometric fluorescence intensity (I489/I552) of S-15 has a linear relationship in the 0–50 μM range of DNA concentrations. It intercalates with DNA through the hydrophobic planar naphthalimide core as confirmed through cyclic voltammetry, circular dichroism, 1H NMR titration, and thermal denaturation studies. Positively charged amine groups also participate in H-bonding with the bases and backbone of DNA. The S-15 intercalator showed a large Stokes shift and photostability, which made it attractive for direct imaging of Legionella pneumophila, without the need for a prior membrane permeabilization.


1 July 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ENElnaz Nazemi
Elnaz Nazemi
WHWalid M. Hassen
Walid M. Hassen
EFEric H. Frost
Eric H. Frost
Jan DubowskiJan Dubowski
Jan Dubowski